Michael J. Woods
Michael J. WoodsChief Executive Officer
Michael Woods serves as Chief Executive Officer for Firma Clinical, applying his nearly 35 years of experience in supporting the developmental needs of pharmaceutical, biotech, and device companies. Prior to joining Firma, Mr. Woods served as Chief Executive Officer for Schulman IRB. During this time Mr. Woods led a period of unprecedented growth and success at Schulman, during which Schulman expanded service offerings, customer base and geographic scope to become a global provider of research compliance services. Throughout this expansion, Schulman maintained a pristine regulatory track record and an outstanding reputation for the quality of their services.

Before joining Schulman, Mr. Woods held several senior management positions in the medical device and biopharma services industry, including Aradigm Corporation where he led Business Development efforts to secure co-development and strategic partnering deals with pharmaceutical and biotech companies worldwide.

Throughout his career in the drug and medical device industries, Mr. Woods has had the opportunity to play a key role in the development of dozens of innovative products and services for a variety of organizations. He is in demand as a member of various commercial and non-profit Boards, industry collaboration efforts, and as a sought-after speaker at numerous conferences, all of which is a testament to his broad understanding of how to maximize the efficiency and effectiveness of development collaborations.

Mr. Woods has a MS with Honors in Molecular Biophysics and Biochemistry from Yale University, and a BS, cum laude, in Biology and Chemistry from Walla Walla University.

Steve Powell
Steve PowellChief Financial Officer
Dr. Dejun (DJ) Tang
Dr. Dejun (DJ) TangSVP, Data Services
Dr. Dejun (DJ) Tang serves as SVP of Data Services for Firma Clinical Research with his nearly 25 years of tenure in biometrics in pharmaceutical and healthcare industry. Before joining Firma, Dr. Tang was Executive Director Biostatistics and Head Biosimilar Biostatistics at Sandoz, a Novartis Division. During the time at Novartis, Dr. Tang led the biostatistics and other function teams supporting all phases of clinical trials in drug development including many NDA and sNDA global submissions and approvals. He has extensive experience on strategic contributions in clinical trial designs and interactions with health authorities in Europe, North America, and Asia. Dr. Tang also played key roles in growing and developing the biometrics teams in Novartis China and Germany.

Prior to Novartis, Dr. Tang worked at Abbott Laboratories and was an assistant professor in statistics at a university in China. Dr. Tang received his Ph.D. in statistics from Purdue University.

Melissa Nezos
Melissa NezosExecutive Vice President, Clinical Operations

Melissa Nezos is Vice President of Clinical Operations at Firma Clinical Research. Since graduating from San Diego State University with a MA in Neuropsychology, Melissa has worked for over 20 years in a number of global organizations within Clinical Operations and Project Management. Her experience spans both large and mid-sized CROs, overseeing large, multi-continent clinical operations teams. In recent years, Melissa has brought her extensive clinical knowledge and expertise into the Risk Based Quality Management and Risk Based Monitoring solutions environment, invited to speak at multiple conferences to present in these areas.

Recognized within the industry as a champion for progression, Melissa has been instrumental in delivering global organizational change initiatives. In addition, she has been an Executive Steering Committee member for several industry competitions for multiple years, advocating progression and excellence within the industry, as well as being active in ACRP initiatives that promote positive change within the industry.

As an advocate for data driven and technology led solutions, she has leveraged her ability to work across operational functions to successfully implement innovative clinical monitoring and data quality strategies. Melissa lives in Cary, North Carolina with her husband and 2 children. When her twins are not keeping her busy, she is an active volunteer for a number of local organizations within the Triangle.

Karen Whitman
Karen WhitmanVP, Corporate Quality & Training
Laurie Parrish
Laurie ParrishAssociate Vice President, Corporate Partnerships

Laurie graduated with a BS in Marketing from the University of North Carolina, Wilmington in 2004. Laurie has over 15 years of sales operations experience within the clinical research, healthcare, and health technology industries, working for large global companies. Laurie has had success with managing diverse teams across all functions of proposal management, contracts, data analytics, training, quality, vendor management, clinical supplies, and logistics. She is focused on strengthened teams, improving process, expanding technologies, and strengthening partner relationships.

Laurie is a native to Nashville and is home based in Collierville, TN with her husband and 5 boys.

Earl Webb Henry, M.D.
Earl Webb Henry, M.D.Consulting Scientist, Board of Directors & former Chief Medical Officer

As the company’s Chief Medical Officer, Dr. Henry will provide leadership and direction for Firma’s clinical development programs.

In 2011, Dr. Henry co-founded H2O Clinical which was rebranded to Firma Clinical Research in 2017. Prior to H2O, Dr. Henry served as the co-Chief Medical Officer of InVentiv Health and Chief Medical Officer of InVentiv Clinical Solutions.

Before InVentiv, Dr. Henry was Head of Clinical Research and Regulatory Affairs at Cephalon, Inc., Head of Clinical Research at Guilford Pharmaceuticals, and Global Head of Central Nervous System Clinical Research at the Sandoz Research Institute. Dr. Henry started his pharmaceutical career at Pfizer Central Research.

Dr. Henry received his medical degree from the University of Chicago (Pritzker) School of Medicine and his bachelor’s degree in Chemistry from the University of Illinois. He was a medical intern at the University of Chicago Hospitals and Clinics and trained in neurology and neuropathology at the Longwood Neurology Program in Boston, which included the Peter Bent Brigham Hospital, Beth Israel Hospital, and Boston Children’s Hospital. Prior to joining Pfizer, Dr. Henry was on staff at Boston Children’s Hospital and Harvard Medical School.

Eugenia Henry, Ph.D.
Eugenia Henry, Ph.D.Consulting Scientist, Board of Directors & former Chief Scientific Officer

Dr. Henry brings more than 29 years of both hands-on and senior level clinical research experience in large pharmaceutical, biotechnology and contract research organizations. Eugenia has served as a statistical consultant and DMC member for many clients and has vast experience in communicating with the FDA for design and statistical issues. To date, Dr. Henry has been actively involved in 56 NDA/sNDA/ANDA/PMA submissions with 52 approvals.

Dr. Henry has leveraged her extensive expertise to create successful data management and statistical services companies such as HHI Clinical Research and Statistical Services which was sold to InVentiv in 2004. Dr. Henry then co-founded H2O Clinical Research in 2011 which merged with Pharma Start in 2016 and was rebranded to Firma Clinical Research in 2017. She has also served in similar roles at Pfizer as the head of Biostatistics and Data Management for the Department of Clinical Pharmacology and Experimental Medicine and at Novartis as the head of Biostatistics and Data Management for Medical Affairs. Dr. Henry received her Ph.D. in Biostatistics from the University of Missouri, Columbia.